OTC · EVLO
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Sep 17, 2026, 8:15 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
EVLO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning EVLO.
EVLO research
Company profile and research snapshot.
EVELO BIOSCIENCES INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 18, 2023 | TD Cowen | Market Perform | — |
| Jul 26, 2023 | Morgan Stanley | Equal-Weight | — |
| Feb 15, 2023 | Morgan Stanley | Equal-Weight | — |
| Nov 16, 2022 | Chardan Capital | Neutral | — |
| Sep 9, 2022 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
defenseworld.net · Nov 27, 2025
Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical volume of 157 put options. Evelo Biosciences Stock Performance NASDAQ: EVLO opened at $0.00 on Thursday. The
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EVLO.
No results
No recent SID articles mention EVLO.
